Brigham Moore competitors

Dr. Wenyuan Shi was appointed Chief Executive Officer and Chief Scientific Officer of the Forsyth Institute on September 1, 2017. Before his appointment, Shi was a chairman and professor of Oral Biology at UCLA Schools of Dentistry. Shi’s laboratory has been using multidisciplinary approaches to study oral microbial pathogenesis with a specific focus on microbial biofilm, inter-species interaction and signal transduction. In addition, Shi’s laboratory is actively involved in the development of next generation diagnostic and therapeutic tools against oral microbial infections, including instant chairside detection of oral pathogens and peptide-based targeted antimicrobial therapeutics. These translational research efforts have resulted in novel technologies that are licensed and developed by major pharmaceutical, dental and biotech companies. Shi is also the founding scientist, chief scientific officer and chairman of the scientific advisory board of C3J Therapeutics Inc. Shi obtained his BS degree from Fudan University in Shanghai in 1984, acquired his PhD degree from the University of Wisconsin-Madison in 1991 and fulfilled his postdoctoral training at the University of California-Berkeley from 1992-1995. He is the co-author of over 200 scientific articles and is credited as co-inventor of 45 patents.